More functional medicine patients are showing up to appointments already enrolled in a ketamine online treatment program, often before their practitioner even knows ketamine is on the table. As at-home ketamine therapy has moved from niche to mainstream, the question for integrative and functional medicine providers isn’t whether to engage with it, but how to do so safely alongside the protocols already driving a patient’s care.
This isn’t a fringe trend. Harvard-affiliated researchers recently completed one of the largest naturalistic comparisons of IV ketamine versus intranasal esketamine, underscoring how much clinical infrastructure now exists around these treatments. For functional medicine practitioners, the practical challenge is coordination: knowing what to communicate to a ketamine therapy from home provider, understanding how ketamine interacts with the supplements and IV protocols already in a patient’s plan, and recognizing when a referral is the right call.
Why Shared Care Coordination Matters
Functional medicine patients are rarely on just one intervention. Between NAD infusions, methylation support, adaptogenic herbs, and hormone optimization, a typical patient’s regimen is complex enough that adding home-based ketamine treatment without coordination creates real risk of blunted efficacy or unexpected interactions.
The good news: most legitimate online ketamine treatment platforms welcome collaboration. Sharing a current medication and supplement list with the prescribing provider, including anything a patient might not think to mention, like herbal tinctures or IV nutrient therapy, lets both sides make informed dosing and scheduling decisions.
How Ketamine Interacts With Common Functional Medicine Protocols
NAD Therapy
There’s limited direct research on combining ketamine with NAD+ infusions, but both influence mitochondrial and neuronal signaling pathways, which is reason enough for practitioners to flag concurrent use to the prescribing clinician. Spacing sessions rather than stacking them on the same day is a reasonable, conservative approach until more data exists.
Methylation Support
Methylation protocols often include high-dose B vitamins, SAMe, or TMG. These aren’t flagged as major interactions, but functional medicine practitioners should be aware that ketamine’s antidepressant mechanism involves glutamate and NMDA receptor modulation: a different pathway than methylation-driven neurotransmitter synthesis. The two aren’t contraindicated, but timing and monitoring conversations are worth having.
Medication Overlap
MAOIs, once assumed to carry serious risk alongside ketamine, have shown no confirmed cases of hypertensive crisis or serotonin syndrome in published case reports, though careful monitoring is still advised. Practitioners managing patients on MAOIs, stimulants, or mood stabilizers should loop in the ketamine provider directly rather than relying on the patient to relay clinical nuance.
When Referral Is the Right Move
Q: Should a functional medicine practitioner ever refer a patient toward, or away from, ketamine treatment?
A: Yes, in both directions. Referral toward ketamine makes sense for patients with treatment-resistant depression, anxiety, or chronic pain who haven’t responded to functional or integrative interventions alone. Referral away, or at least a pause, is appropriate for patients with uncontrolled hypertension, active substance use, or unmanaged bipolar disorder, since ketamine can carry cardiovascular and psychiatric risks in those populations.
Q: What should a functional medicine practitioner communicate to a telehealth ketamine provider?
A: A full, current list of supplements, IV protocols, prescription medications, and any recent dosage changes, plus relevant labs if available. Providers offering ketamine nasal spray, ketamine troches, or infusion-based psychedelic-assisted therapy typically conduct their own intake, but functional medicine context fills in gaps a standard psychiatric intake might miss.
Care That Continues Beyond the Prescription
The conversation around psychedelic-assisted care has shifted in recent years. Rather than treating a single dose as the destination, clinicians and researchers increasingly view it as one part of a longer arc, one that includes screening, preparation, the treatment itself, and the reflection that comes after.
Not every telehealth platform is built to support that full arc, but Daytryp RX offers a model worth noting. As a LegitScript-certified provider, the platform pairs at-home ketamine therapy with licensed physician oversight and unlimited messaging access, so patients pursuing ketamine therapy from home aren’t left to navigate the process alone.
Ready to explore provider-guided at-home ketamine therapy? Get started with Daytryp RX to see if you’re eligible.
About the Author
This article was contributed by the team at Daytryp RX, a telehealth provider committed to expanding access to personalized mental health and wellness care. Through provider-guided ketamine therapy, medical weight management, hormone optimization, and ongoing clinical support, Daytryp RX helps eligible patients pursue meaningful improvements in their emotional and physical well-being through convenient virtual care.
